| Product Code: ETC13370590 | Publication Date: Apr 2025 | Updated Date: Aug 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
| Market Size (2025) | USD 2.3 Billion |
| Forecast Size (2032) | USD 3.4 Billion |
| CAGR | 4.70% |
| Base Year | 2025 |
| Forecast Period | 2026-2032 |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Largest Segment | Ultrasound Screening |
| Fastest Growing Segment | CT Angiography |
| Leading Companies | Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Samsung Medison |

The Global Vascular Screening Market was estimated at USD 2.3 Billion in 2025 and is projected to reach USD 3.4 Billion by 2032, growing at a CAGR of 4.70% from 2026 to 2032.
As vascular diseases rise globally due to an aging population, the Global Vascular Screening Market is undergoing significant transformation. Early detection through advanced screening techniques is becoming essential for managing chronic conditions such as Peripheral Artery Disease and aneurysms.
Particularly, the shift toward non-invasive methods like ultrasound is indicative of evolving healthcare demands. Coupled with governmental pushes for preventive care, this market occupies a critical niche in enhancing public health outcomes and tackling healthcare costs.
This graph illustrates the annual growth rates of the Global Vascular Screening Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate (%) | Major Drivers |
| 2022 | 6.75 | Hospitals are increasingly adopting vascular screening technologies to improve patient outcomes. |
| 2023 | 6.19 | Advancements in FDA approvals for vascular diagnostic tools are accelerating market competition. |
| 2024 | 4.87 | Growing interest in vascular screening initiatives enhances regional healthcare infrastructure development. |
| 2025 | 5.6 | A favorable economic climate is driving investment in vascular screening equipment manufacturing. |
| 2026 | 6.07 | Biosensor technology enhancements are shaping regulatory frameworks around vascular screening applications. |
| 2027 | 5.84 | Healthcare providers are expanding their workforce capabilities to enhance vascular screening services. |
| 2028 | 4.94 | Patients are increasingly seeking proactive vascular screening for better chronic disease management. |
| 2029 | 7.63 | Integrating sustainability practices is transforming vascular screening technological development processes. |
| 2030 | 3.98 | As investment in telehealth platforms increases, vascular screening access is becoming more widespread. |
| 2031 | 3.59 | In North America, supply chain adjustments are optimizing vascular screening product availability. |
| 2032 | 8.23 | A shift toward innovative wearable monitoring devices is redefining vascular screening methodologies. |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.
Below are some of the specific key takeaways from the market, including:
Despite robust growth prospects, several restraints challenge the Global Vascular Screening Market's potential. One significant barrier is the high cost of advanced screening equipment, with some systems exceeding USD 100,000, which may deter hospitals and clinics from investing in new technologies. For example, the lack of insurance coverage for certain screening procedures leads to underutilization and, in turn, lower market penetration. A further obstacle includes a shortage of trained professionals skilled in vascular screening, which could result in a bottleneck for providing timely diagnostics.
The Global Vascular Screening Market is presently marked by significant trends driven by technology and healthcare dynamics. Firstly, the increasing incorporation of artificial intelligence (AI) into diagnostic tools is enhancing screening accuracy. For instance, Siemens Healthineers is integrating AI features in its imaging devices to improve detection rates of vascular abnormalities, reflecting a transformative shift in practice. Another trend is the movement toward portable imaging devices, which caters to remote populations. Research indicates that the portable ultrasound market could experience growth approaching 8.5% CAGR from 2026 to 2032, making advanced vascular screening accessible in underserved regions.
Future revenue opportunities in the Global Vascular Screening Market notably align with technological advancements and health policy shifts. Development of cost-effective, portable vascular screening devices is one avenue, particularly targeting rural and under-resourced areas. For example, Philips Healthcare is investing in micro-ultrasound technology, anticipated to enable effective vascular diagnostics at approximately a third of the price of traditional systems, potentially unlocking new markets. Furthermore, partnerships between healthcare providers and technology firms are increasing operational efficiencies. Collaborative projects aim to enhance telehealth capabilities, thereby broadening access to crucial diagnostics in real-time.
In the Global Vascular Screening Market, Ultrasound Screening currently commands a significant share, approximately ~55% in 2025, owing to its non-invasive nature and cost efficiency. Conversely, CT Angiography is projected to be the fastest-growing segment, with a CAGR of 6.2% from 2026 to 2032, driven by technological advancements offering superior detail and rapid imaging capabilities. These technologies cater to varied applications, with ultrasound being preferred in routine checks and CT angiography excelling in complex diagnosis scenarios.
The leading disease type in the Global Vascular Screening Market is Peripheral Artery Disease, expected to hold a ~40% share in 2025 due to rising prevalence linked to lifestyle factors. Aneurysms, however, represent the fastest-growing segment, projected to experience a CAGR of 5.5% from 2026 to 2032. This growth reflects increased awareness and early detection initiatives, which are crucial for reducing mortality associated with aneurysms.
Hospitals are the largest end-user segment in the Global Vascular Screening Market, accounting for approximately ~65% share in 2025, owing to their comprehensive diagnostic and treatment capabilities. In contrast, clinics represent the fastest-growing segment, with a projected CAGR of 6.1% from 2026 to 2032 as they expand services to cater to preventive care demands. Increased investments in outpatient services drive this transition, offering patients greater access to essential screening.
North America is currently the largest region in the Global Vascular Screening Market, commanding approximately ~48% share in 2025, largely attributable to its advanced healthcare infrastructure and high per capita healthcare spending. Meanwhile, the Asia-Pacific region exhibits promise as the fastest-growing segment, expected to witness a CAGR of 6.0% from 2026 to 2032, fueled by investments in healthcare infrastructure and increasing prevalence of cardiovascular conditions.
The regulatory and policy environment surrounding the Global Vascular Screening Market is becoming increasingly supportive as governments acknowledge the critical need for preventive healthcare services. Such initiatives not only aim to improve public health outcomes but also seek to reduce long-term healthcare costs through early detection and treatment.
The Global Vascular Screening Market is expected to undergo significant shifts as healthcare providers increasingly embrace telehealth solutions and portable diagnostic technologies. As seen with Philips Healthcare's investment in micro-ultrasound technology, there is a clear trend toward cost-effective, accessible screening options. This transformation aligns with rising patient demand for immediate healthcare access, particularly in under-resourced areas. By 2032, these advancements are likely to reshape traditional diagnostic practices, enhancing patient care and operational efficiencies across the sector.
Recent advancements in the Global Vascular Screening Market highlight the ongoing efforts by leading companies to enhance their offerings and market positions. These developments not only signify technological progress but also reflect strategic initiatives aimed at addressing evolving healthcare needs.
The competitive structure of the Global Vascular Screening Market is marked by a fragmented landscape, with several key players vying for market share through strategic innovations and regional expansions. Companies are distinguishing themselves based on technological advancements, product offerings, and collaborative efforts within the healthcare ecosystem.
| Leading Company | Core Strength | Strategic Focus |
|---|---|---|
| Siemens Healthineers | Strong in advanced imaging technologies | Integrating AI into diagnostic tools |
| GE Healthcare | Leader in medical imaging and software | Enhancing diagnostic accuracy with AI |
| Philips Healthcare | Expertise in portable imaging solutions | Investing in micro-ultrasound technologies |
| Canon Medical Systems | Diverse imaging solutions portfolio | Focus on developing portable imaging systems |
| Samsung Medison | Strong presence in ultrasound technology | Expanding into emerging markets |
As the competitive environment evolves, companies are likely to continue prioritizing innovation and strategic partnerships to address healthcare challenges and meet the growing demand for vascular screening.
Global Vascular Screening Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Vascular Screening Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Vascular Screening Market Revenues & Volume, 2022 & 2032F |
3.3 Global Vascular Screening Market - Industry Life Cycle |
3.4 Global Vascular Screening Market - Porter's Five Forces |
3.5 Global Vascular Screening Market Revenues & Volume Share, By Regions, 2022 & 2032F |
3.6 Global Vascular Screening Market Revenues & Volume Share, By Test Type, 2022 & 2032F |
3.7 Global Vascular Screening Market Revenues & Volume Share, By Disease Type, 2022 & 2032F |
3.8 Global Vascular Screening Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Global Vascular Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Vascular Screening Market Trends |
6 Global Vascular Screening Market, 2022-2032 |
6.1 Global Vascular Screening Market, Revenues & Volume, By Test Type, 2022-2032 |
6.1.1 Overview & Analysis |
6.1.2 Global Vascular Screening Market, Revenues & Volume, By Ultrasound Screening, 2022-2032 |
6.1.3 Global Vascular Screening Market, Revenues & Volume, By CT Angiography, 2022-2032 |
6.2 Global Vascular Screening Market, Revenues & Volume, By Disease Type, 2022-2032 |
6.2.1 Overview & Analysis |
6.2.2 Global Vascular Screening Market, Revenues & Volume, By Peripheral Artery Disease, 2022-2032 |
6.2.3 Global Vascular Screening Market, Revenues & Volume, By Aneurysms, 2022-2032 |
6.3 Global Vascular Screening Market, Revenues & Volume, By End User, 2022-2032 |
6.3.1 Overview & Analysis |
6.3.2 Global Vascular Screening Market, Revenues & Volume, By Hospitals, 2022-2032 |
6.3.3 Global Vascular Screening Market, Revenues & Volume, By Clinics, 2022-2032 |
7 North America Vascular Screening Market, Overview & Analysis |
7.1 North America Vascular Screening Market Revenues & Volume, 2022-2032 |
7.2 North America Vascular Screening Market, Revenues & Volume, By Countries, 2022-2032 |
7.2.1 United States (US) Vascular Screening Market, Revenues & Volume, 2022-2032 |
7.2.2 Canada Vascular Screening Market, Revenues & Volume, 2022-2032 |
7.2.3 Rest of North America Vascular Screening Market, Revenues & Volume, 2022-2032 |
7.3 North America Vascular Screening Market, Revenues & Volume, By Test Type, 2022-2032 |
7.4 North America Vascular Screening Market, Revenues & Volume, By Disease Type, 2022-2032 |
7.5 North America Vascular Screening Market, Revenues & Volume, By End User, 2022-2032 |
8 Latin America (LATAM) Vascular Screening Market, Overview & Analysis |
8.1 Latin America (LATAM) Vascular Screening Market Revenues & Volume, 2022-2032 |
8.2 Latin America (LATAM) Vascular Screening Market, Revenues & Volume, By Countries, 2022-2032 |
8.2.1 Brazil Vascular Screening Market, Revenues & Volume, 2022-2032 |
8.2.2 Mexico Vascular Screening Market, Revenues & Volume, 2022-2032 |
8.2.3 Argentina Vascular Screening Market, Revenues & Volume, 2022-2032 |
8.2.4 Rest of LATAM Vascular Screening Market, Revenues & Volume, 2022-2032 |
8.3 Latin America (LATAM) Vascular Screening Market, Revenues & Volume, By Test Type, 2022-2032 |
8.4 Latin America (LATAM) Vascular Screening Market, Revenues & Volume, By Disease Type, 2022-2032 |
8.5 Latin America (LATAM) Vascular Screening Market, Revenues & Volume, By End User, 2022-2032 |
9 Asia Vascular Screening Market, Overview & Analysis |
9.1 Asia Vascular Screening Market Revenues & Volume, 2022-2032 |
9.2 Asia Vascular Screening Market, Revenues & Volume, By Countries, 2022-2032 |
9.2.1 India Vascular Screening Market, Revenues & Volume, 2022-2032 |
9.2.2 China Vascular Screening Market, Revenues & Volume, 2022-2032 |
9.2.3 Japan Vascular Screening Market, Revenues & Volume, 2022-2032 |
9.2.4 Rest of Asia Vascular Screening Market, Revenues & Volume, 2022-2032 |
9.3 Asia Vascular Screening Market, Revenues & Volume, By Test Type, 2022-2032 |
9.4 Asia Vascular Screening Market, Revenues & Volume, By Disease Type, 2022-2032 |
9.5 Asia Vascular Screening Market, Revenues & Volume, By End User, 2022-2032 |
10 Africa Vascular Screening Market, Overview & Analysis |
10.1 Africa Vascular Screening Market Revenues & Volume, 2022-2032 |
10.2 Africa Vascular Screening Market, Revenues & Volume, By Countries, 2022-2032 |
10.2.1 South Africa Vascular Screening Market, Revenues & Volume, 2022-2032 |
10.2.2 Egypt Vascular Screening Market, Revenues & Volume, 2022-2032 |
10.2.3 Nigeria Vascular Screening Market, Revenues & Volume, 2022-2032 |
10.2.4 Rest of Africa Vascular Screening Market, Revenues & Volume, 2022-2032 |
10.3 Africa Vascular Screening Market, Revenues & Volume, By Test Type, 2022-2032 |
10.4 Africa Vascular Screening Market, Revenues & Volume, By Disease Type, 2022-2032 |
10.5 Africa Vascular Screening Market, Revenues & Volume, By End User, 2022-2032 |
11 Europe Vascular Screening Market, Overview & Analysis |
11.1 Europe Vascular Screening Market Revenues & Volume, 2022-2032 |
11.2 Europe Vascular Screening Market, Revenues & Volume, By Countries, 2022-2032 |
11.2.1 United Kingdom Vascular Screening Market, Revenues & Volume, 2022-2032 |
11.2.2 Germany Vascular Screening Market, Revenues & Volume, 2022-2032 |
11.2.3 France Vascular Screening Market, Revenues & Volume, 2022-2032 |
11.2.4 Rest of Europe Vascular Screening Market, Revenues & Volume, 2022-2032 |
11.3 Europe Vascular Screening Market, Revenues & Volume, By Test Type, 2022-2032 |
11.4 Europe Vascular Screening Market, Revenues & Volume, By Disease Type, 2022-2032 |
11.5 Europe Vascular Screening Market, Revenues & Volume, By End User, 2022-2032 |
12 Middle East Vascular Screening Market, Overview & Analysis |
12.1 Middle East Vascular Screening Market Revenues & Volume, 2022-2032 |
12.2 Middle East Vascular Screening Market, Revenues & Volume, By Countries, 2022-2032 |
12.2.1 Saudi Arabia Vascular Screening Market, Revenues & Volume, 2022-2032 |
12.2.2 UAE Vascular Screening Market, Revenues & Volume, 2022-2032 |
12.2.3 Turkey Vascular Screening Market, Revenues & Volume, 2022-2032 |
12.3 Middle East Vascular Screening Market, Revenues & Volume, By Test Type, 2022-2032 |
12.4 Middle East Vascular Screening Market, Revenues & Volume, By Disease Type, 2022-2032 |
12.5 Middle East Vascular Screening Market, Revenues & Volume, By End User, 2022-2032 |
13 Global Vascular Screening Market Key Performance Indicators |
14 Global Vascular Screening Market - Export/Import By Countries Assessment |
15 Global Vascular Screening Market - Opportunity Assessment |
15.1 Global Vascular Screening Market Opportunity Assessment, By Countries, 2022 & 2032F |
15.2 Global Vascular Screening Market Opportunity Assessment, By Test Type, 2022 & 2032F |
15.3 Global Vascular Screening Market Opportunity Assessment, By Disease Type, 2022 & 2032F |
15.4 Global Vascular Screening Market Opportunity Assessment, By End User, 2022 & 2032F |
16 Global Vascular Screening Market - Competitive Landscape |
16.1 Global Vascular Screening Market Revenue Share, By Companies, 2025 |
16.2 Global Vascular Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here